LYELL IMMUNOPHARMA, INC.

Profile

Company Names

LYELL IMMUNOPHARMA, INC.

Addresses

400 EAST JAMIE COURT, SUITE 301, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

650 695-0677

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$492,999,957.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-03-05 
$492,999,957.00 
$492,999,957.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HANS 
 
BISHOP 
DIRECTOR
JUNO THERAPEUTICS, INC.   |  GRAIL, INC.   |  LYELL IMMUNOPHARMA, INC.   |  SANA BIOTECHNOLOGY, INC.   |  OPHIREX, INC.
CATHERINE 
 
FRIEDMAN 
DIRECTOR
ENTEROMEDICS INC   |  GRAIL, INC.   |  LYELL IMMUNOPHARMA, INC.
RICHARD 
 
GOOLD 
EXECUTIVE OFFICER
STATION X INC.   |  LYELL IMMUNOPHARMA, INC.
STEPHEN 
 
HILL 
EXECUTIVE OFFICER
SHEER WIND, INC.   |  FARADAY PHARMACEUTICALS, INC.   |  LYELL IMMUNOPHARMA, INC.   |  RESOLYS BIO, INC.   |  KRYGER EVENT FUND LP   |  BOTANICA VENTURES LLC
ELIZABETH 
 
HOMANS 
EXECUTIVE OFFICER
LYELL IMMUNOPHARMA, INC.   |  DELFI DIAGNOSTICS, INC.
RICHARD 
 
KLAUSNER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
IMMUNE DESIGN CORP.   |  JUNO THERAPEUTICS, INC.   |  GRAIL, INC.   |  MINDSTRONG, INC.   |  LIFEMINE THERAPEUTICS, INC.   |  MEDICAL CREATIONS, INC.   |  LYELL IMMUNOPHARMA, INC.   |  SONOMA BIOTHERAPEUTICS, INC.
ROBERT 
 
NELSON 
DIRECTOR
RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)   |  TRADEHARBOR INC   |  WISCONSIN BANCSHARES, INC.   |  AXION POWER INTERNATIONAL, INC.   |  CALLMINER, INC.   |  LB REIT LLC   |  GLOBAL ONE PROMENADE CO-INVESTMENT LLC   |  GLOBAL LANDS END LLC   |  SIENNA LABS, INC.   |  GLOBAL ONE REAL ESTATE FUND II, L.P.   |  BEAM THERAPEUTICS INC.   |  LYELL IMMUNOPHARMA, INC.   |  GLOBAL ONE 36TH CO-INVESTMENT LLC   |  EVERGREEN GARDENS, INC.   |  CLRS X LLC   |  FINNEY S11 1 JOINT VENTURE   |  FINNEY S11 2 JOINT VENTURE   |  TITUS 1 JOINT VENTURE   |  MINDIMMUNE THERAPEUTICS, INC.   |  NORTH TITUS 1 JOINT VENTURE
NICHOLAS 
 
RESTIFO 
EXECUTIVE OFFICER
LYELL IMMUNOPHARMA, INC.
STAN 
 
RIDDELL 
EXECUTIVE OFFICER
CERO THERAPEUTICS, INC.   |  LYELL IMMUNOPHARMA, INC.
MARGO 
 
ROBERTS 
EXECUTIVE OFFICER
INSTIL BIO, INC.   |  LYELL IMMUNOPHARMA, INC.
HEATHER 
 
TURNER 
EXECUTIVE OFFICER
AGRE DCP OAKLAND CITY CENTER REIT LLC   |  AGRE DCP PALM SPRINGS REIT LLC   |  CERO THERAPEUTICS, INC.   |  LYELL IMMUNOPHARMA, INC.   |  CARMOT THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-03-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#